Top in ID: Persistent SARS-CoV-2 infections; longer intervals between vaccine doses
The top stories in infectious disease last week focused on research that was recently presented at the European Congress of Clinical Microbiology and Infectious Diseases in Lisbon, Portugal.
One story reviewed the case of a patient who tested positive for SARS-CoV-2 for 505 consecutive days. In a video interview, Luke B. Snell, MD, MSc, MBBS, from Guy’s and St. Thomas’ NHS Foundation Trust in London, said that persistent infections may help uncover information on the origins of SARS-CoV-2 variants.
Another top story was about a study that found longer intervals between COVID-19 vaccine doses produced higher antibody levels. Amesh A. Adalja, MD, senior scholar at Johns Hopkins Center for Health Security, said the findings provide “more evidence that the 3-to-4-week dosing interval used for COVID-19 messenger RNA vaccines was suboptimal.”
Read the top stories in infectious disease below:
VIDEO: Patient infected with SARS-CoV-2 for 505 consecutive days
In this video, Snell explains the case of a patient who tested positive for SARS-CoV-2 for 505 consecutive days — thought to be a record. Read more.
Longer intervals between COVID-19 vaccine doses produce higher antibody levels
A study conducted among health care workers in the United Kingdom demonstrated that longer intervals between COVID-19 vaccine doses produced higher antibody levels, researchers reported here. Read more.
VIDEO: Virologist Angela Rasmussen, PhD, on safely attending conferences
In this video, virologist Angela Rasmussen, PhD, discusses the steps she is taking to safely attend the European Congress of Clinical Microbiology and Infectious Diseases in person. Read more.
US study finds some increase in resistant infections during pandemic
An analysis of antimicrobial resistance at more than 270 U.S. hospitals found some increase during the first 20 months of the COVID-19 pandemic compared with the prior 8 months. Read more.
VIDEO: Carlos del Rio, MD, on the clinical benefits of Twitter
In this video, Carlos del Rio, MD, executive associate dean at Emory University School of Medicine, discusses the clinical benefits of being active on Twitter. Read more.